Depression in Older Adults: Diagnosis, Treatment, and Support
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Depression in older adults is a treatable mental health condition that can affect mood, motivation, enjoyment, physical health, cognition, everyday independence, and relationships. In later life, a depressive disorder may first become evident through exhaustion, withdrawal, loss of interest, sleep problems, unexplained functional change, or memory complaints. Persistent symptoms deserve clinical evaluation, including consideration of medical illness, medication effects, and cognitive disorders. Depression is not an inevitable consequence of aging. The National Institute on Aging and the National Institute of Mental Health emphasize recognition and access to treatment.
This guide explains the signs, clinical diagnosis, age-specific risk factors, cognitive differential diagnosis, evidence-based psychotherapy and antidepressant care, specialist treatment options, and practical ways to help a parent, spouse, relative, friend, or patient. Its focus is unipolar depression in later life; general dementia care, bipolar disorder, grief diagnoses, and the broad science of aging have their own clinical pathways.
For related clinical context, see Depression: Symptoms, Causes, Diagnosis, and Treatment.
I. What Is Depression in Older Adults?
Late-life depression is a descriptive expression for depressive disorders or clinically significant depressive symptoms occurring in later adulthood. Research sometimes defines older age as 60 years and sometimes as 65 years or older. The age label is not itself a distinct DSM-5-TR or ICD-11 disorder. Older adults may experience major depressive disorder (MDD), persistent depressive disorder, other depressive conditions, or depressive symptoms that do not meet the full diagnostic threshold. Symptoms can first appear in old age or represent another episode in a recurrent illness.
1. Depressed mood, depressive episode, and disorder
Depressed mood is a symptom. A major depressive episode is a specified syndrome that generally includes depressed mood or loss of interest or pleasure, plus additional symptoms lasting at least two weeks and causing clinically significant distress or impairment. Major depressive disorder is diagnosed when the episode and applicable criteria and exclusions are met. Persistent depressive disorder has a longer-term course with distinct diagnostic requirements. Subthreshold depressive symptoms can still cause considerable disability and deserve appropriate evaluation. An online checklist cannot establish whether someone has any of these diagnoses. See NIMH's clinical overview and the USPSTF recommendation.
2. Depression is not normal aging
Older people may encounter serious illness, disability, caregiving demands, retirement transitions, financial insecurity, social disconnection, and death of loved ones. These circumstances can influence emotional health, but none makes a clinical depressive disorder an expected consequence of growing older. Many people maintain emotional resilience through substantial change. Attributing persistent hopelessness, anhedonia, or major decline in functioning to age can delay effective care. NIA states directly that depression is not a normal part of aging.
3. Why older adults' depression can be overlooked
Some older adults describe depression primarily as fatigue, pain, loss of energy, inability to initiate tasks, or difficulty following conversations. Others express little overt sadness but have stopped enjoying almost everything. Cultural expressions of distress, stigma, hearing problems, limited appointment time, and multiple medical diagnoses complicate recognition. Families may misinterpret withdrawal as stubbornness, or clinicians may focus exclusively on physical illness. A sensitive assessment establishes what changed from the individual's own baseline and asks about pleasure, motivation, guilt, anxiety, safety, sleep, appetite, functioning, and cognition.
II. Signs and Symptoms
Clinical presentation differs among individuals and across episodes. Some people appear polite and socially capable while struggling internally; others lose their customary ability to care for themselves. Symptoms require assessment for persistence, context, associated impairment and potential medical causes. The NIMH older-adult resource discusses common presentations.
• Emotional symptoms: sadness, emptiness, irritability, hopelessness, guilt, worthlessness, anxiety, or loss of confidence. Anhedonia—the loss of interest or pleasure—can be central even without prominent descriptions of sadness.
• Behavioral symptoms: withdrawing from friends, abandoning valued activities, reduced self-care, slowing of movement or speech, difficulty preparing meals, managing routines, or attending appointments.
• Physical symptoms: fatigue, disrupted sleep, appetite or weight changes, reduced physical activity, and sometimes physical discomfort that requires independent medical evaluation.
• Cognitive symptoms: reduced concentration, indecision, slowed thinking, difficulties organizing tasks, or memory complaints. These can also reflect delirium, medication effects, neurologic disease, or other conditions.
• Safety-related symptoms: statements about wishing to die, being a burden, feeling that others would be better off without them, suicidal thinking, or behavior. These require direct professional attention.
4. Can older adults have depression without sadness?
Yes. In some people the most apparent change is loss of pleasure, motivation or capacity to engage. A clinician explores the patient's experience, the presence of anhedonia, and associated symptoms. Low drive alone is not equivalent to depression: apathy associated with neurologic illness, severe fatigue, pain, medication adverse effects, and limitations in mobility may appear similar. Clinical reasoning evaluates the combined symptom pattern.
5. “Smiling” and “high-functioning” depression
“Smiling depression” and “high-functioning depression” are popular descriptions of an outwardly capable person who may experience depressive symptoms. Neither is an independent DSM-5-TR or ICD-11 diagnosis. A person with a depressive disorder may continue working, organizing a household, or maintaining a friendly demeanor, although such outward behavior does not establish the diagnosis. The clinical questions concern the duration, characteristic symptoms, functional effects, and relevant diagnostic exclusions.
III. Causes and Risk Factors in Later Life
Depression in older adulthood develops through interactions among previous mental health history, physical health, psychosocial stress, vulnerabilities, and the person's environment. A previous depressive episode, persistent pain, disability, sleep difficulties, social isolation, bereavement, caregiving strain, or restricted access to support may contribute. A risk factor increases probability at a population level but is neither proof of a causal mechanism in one person nor evidence that a depressive disorder is present. NIMH and NIA outline overlapping factors.
6. Chronic illnesses and hospitalizations
Cardiovascular disease, stroke, diabetes, chronic lung disease, cancer, chronic pain, sleep disorders, and neurologic problems can coexist with depression. A new medical diagnosis may disrupt sleep, independence, mobility, and social participation. Some medical symptoms resemble depressive symptoms, creating a difficult differential diagnosis. New depression following hospitalization or a stroke warrants coordinated psychiatric and medical assessment rather than attributing every problem solely to psychological stress.
7. Medicines and substance effects
Changes in prescriptions, sedating drugs, adverse effects, or interactions can affect alertness, mood, appetite, and cognition. Medication reconciliation should cover prescriptions from every clinician, over-the-counter products, supplements, alcohol, and other substances. The evaluator considers timing, dose changes, physical health, and possible withdrawal states. There is no universally required laboratory test panel; investigations follow clinical indications. NICE's depression guideline directs attention to coexisting illness and interactions in treatment decisions.
8. Loneliness, loss and practical conditions
Living alone is different from loneliness. One person may thrive in an independent household while another feels disconnected among many relatives. Loss of a spouse, financial strain, unsafe housing, inaccessible transport, disability, discrimination, and lack of meaningful activities may affect well-being or limit treatment access. These circumstances should inform a care plan. They do not justify reducing a depressive illness to one presumed social cause, and their presence does not make the illness unresponsive to psychotherapy or medication.
9. What neuroscience contributes
Research on late-life depression studies brain circuitry, vascular processes, executive functioning, emotion regulation, reward processing, inflammation, and relationships with neurodegenerative conditions. These literatures are heterogeneous. Some findings are correlational, and there is no validated routine brain scan, inflammation marker, or neurotransmitter measurement that diagnoses depression in an individual patient. Imaging can be useful for an independent neurologic indication; the depressive disorder itself is assessed clinically.
IV. Depression, Memory Problems, Delirium and Dementia
One of the most important challenges in later life is deciding what explains changes in memory, organization, attention, or everyday independence. Depression may cause slowed processing, diminished concentration, difficulty retrieving information, reduced motivation, and impaired executive function. These cognitive difficulties are real. Some improve with treatment, some persist, and some arise alongside mild cognitive impairment or dementia. Identifying depression therefore does not eliminate the need to consider neurocognitive disease.
10. Depression versus dementia
A clinician assesses the course of change, prior functioning, medical history, subjective complaints, objective cognitive performance, activities of daily living and neurologic findings. Depression-related cognitive complaints and progressive neurocognitive disorders can overlap and coexist; one bedside sign cannot reliably distinguish them. Hearing, vision, educational and language differences also affect testing. The older phrase “pseudodementia” is misleading if it suggests that depression-related impairment is imaginary or necessarily reversible. When concerns persist, additional cognitive evaluation and longitudinal review are appropriate.
11. Depression versus delirium
Delirium is characterized by an acute or fluctuating change in attention and awareness and may accompany infections, dehydration, medications, hospitalization, or other medical problems. Abrupt confusion, changing alertness, or severe disorientation—especially after an illness, fall, or medication change—requires urgent medical assessment. A previous diagnosis of depression must never be used to dismiss the possibility of an acute medical syndrome. Depression and delirium can coexist.
12. Depression alongside dementia
Depressive symptoms may appear in a person already diagnosed with dementia. Communication difficulties and changes in motivation complicate symptom assessment, so clinicians adapt interviews and may seek additional observations from trusted caregivers with appropriate consent. The patient should participate in decisions to the extent possible. Treatment may involve adjustment of activities, psychological support, pain and sleep care, and careful medication review. Care for the underlying neurocognitive disorder continues independently.
13. Apathy and grief
Apathy refers to reduced goal-directed motivation and occurs in several neurologic and psychiatric conditions. Grief after a loss often includes yearning and waves of painful emotion that may change with reminders. A major depressive episode or a grief-related disorder can also occur after bereavement. The clinician examines the full pattern, degree of pervasive anhedonia, impairment, duration, and safety concerns. The detailed diagnosis of prolonged grief and the general science of dementia belong to their respective clinical specialties.
V. How Clinicians Diagnose Depression in Older Adults
The diagnostic process integrates clinical interview, symptoms and duration, functional change, previous episodes, physical and medication history, mental status, and safety. When appropriate and with consent, family observations can clarify changes in behavior and everyday function. The purpose is to identify the correct syndrome, potential coexisting disorders, and a treatment plan appropriate to the individual's goals. There is no single blood test or online score that establishes major depressive disorder. NIMH.
14. Clinical interview and differential diagnosis
An assessment asks when symptoms began, whether enjoyment changed, how sleeping and eating have been affected, what everyday tasks became difficult, and how much distress exists. It reviews physical illness, recent hospitalizations, pain, cognitive change, current medication, substance use, and previous treatments. Clinicians also ask directly about suicidal thinking, psychotic symptoms, and inability to meet basic needs. Sudden neurologic changes or confusion require a separate medical pathway.
15. Why bipolar symptoms must be checked
A depressive episode can occur in bipolar disorders. Before choosing antidepressant treatment for apparently unipolar depression, clinicians inquire about prior episodes of unusually elevated or irritable mood, marked increases in energy or activity, reduced need for sleep, pressured speech, impulsive behavior or other signs of mania or hypomania. Mixed features also affect risk and treatment decisions. Undetected bipolar disorder can require a different medication strategy and specialist input. This article addresses depression in later life; bipolar illness is a separate diagnostic and treatment domain.
16. What PHQ-9 and the Geriatric Depression Scale can tell us
The U.S. Preventive Services Task Force's June 2023 recommendation supports depression screening in adults including those aged 65 and older, accompanied by systems for diagnostic assessment and effective care after positive results. Tools such as the PHQ-2, PHQ-9 and Geriatric Depression Scale identify possible symptoms and can help monitor treatment. They do not independently diagnose major depressive disorder, establish etiology, or determine treatment. Their responses need interpretation in light of chronic illness, cognitive capacity and other causes of sleep, fatigue and appetite changes.
The same USPSTF statement found insufficient evidence to assess the balance of benefits and harms of routine suicide-risk screening among asymptomatic adults. This should not be confused with the obligation to assess and respond to suicidal thoughts, intent, or acute danger when they are reported or suspected. Screening policy and emergency clinical safety assessment answer different questions.
17. Severity, specifiers and clinical status
Mild, moderate and severe depression are clinical assessments of symptom burden, functioning and safety, not conclusions drawn from one scale. Major depressive disorder may be qualified by specific diagnostic specifiers when their criteria are met, such as melancholic features, atypical features, psychotic features or a seasonal pattern. “Seasonal affective disorder” is commonly used shorthand for depression with a seasonal pattern, while the formal classification depends on the applicable diagnostic system. Psychotic depression is an urgent specialist issue, and seasonal fatigue alone does not establish a seasonal-pattern mood disorder. “Smiling depression” remains a popular phrase rather than a specifier.
VI. Treating Depression in Older Adults
Effective treatment is selected according to clinical severity, patient preferences, prior response, physical health, cognition, drug interactions, mobility, living circumstances, and risk. Psychotherapy, antidepressants, their combination, and coordinated follow-up have roles. A good care plan includes clear goals for daily functioning, a review schedule, assessment of adverse effects, and practical access to treatment. NICE NG222 provides a framework for shared decision-making, while the American Psychological Association's older-adult resource outlines evidence-based interventions.
18. Psychotherapy
Cognitive behavioral therapy (CBT) can address patterns of thinking and behavior that accompany depression; behavioral activation helps people rebuild rewarding activity in feasible steps; interpersonal psychotherapy addresses relationship difficulties and role transitions; problem-solving approaches can support practical coping. Therapies should be adapted to hearing and vision, mobility, cognitive capacity, pace of learning, and cultural preferences. Telehealth or telephone appointments can expand access for some patients but may be unsuitable for others. A person with physical illness or retirement-related transitions can still benefit from structured psychotherapy. APA.
19. Long-term care residents
People living in nursing homes or assisted living settings may contend with pain, limited privacy, reduced autonomy, loneliness, and difficulty reaching therapists. A 2024 Cochrane review concluded that cognitive behavioral, behavioral, and reminiscence therapies may reduce depressive symptoms in long-term care residents compared with usual care. The evidence was very uncertain, however, with limited confidence in the observed effects and their durability. Facilities should make appropriate psychological support available and monitor actual outcomes rather than assuming any one intervention works for every resident.
20. Antidepressants and shared decisions
Second-generation antidepressants, including selective serotonin reuptake inhibitors and other indicated classes, can be appropriate for major depression in later life. Choice follows the person's previous benefit, symptom pattern, comorbidities, drug interactions, preferences, and willingness to attend follow-up. Medication may be combined with psychotherapy, particularly where symptoms are more persistent, severe, or recurrent. The APA guidance for older adults discusses second-generation agents and psychological treatments.
Older adults may be particularly vulnerable to hyponatremia, dizziness and falls, fractures, bleeding with some drug combinations, cardiac effects, sedation, and cognitive adverse effects depending on the medication and comorbidities. Anticholinergic burden and polypharmacy also matter. No individual antidepressant is universally safest for everyone older than 65. NICE NG222 recommends reviewing physical illness and interactions, falls and fractures, and sodium-related risk, particularly with diuretics. Clinicians monitor response, functioning and adverse effects rather than simply renewing prescriptions indefinitely.
21. Starting, continuing and stopping medication
Patients should receive an explanation of the expected course of improvement, possible adverse effects, appropriate review arrangements, and signs requiring prompt medical attention. Treatment needs sufficient time for a fair evaluation while avoiding prolonged ineffective or poorly tolerated regimens. Discontinuing antidepressants abruptly can cause withdrawal symptoms; a gradual, individually planned reduction with clinical support is often appropriate. Withdrawal can resemble recurrence, so symptom timing and pattern matter. Patients and families should contact the prescriber before stopping or changing doses. NICE's discontinuation recommendations emphasize patient-led pacing and monitoring.
22. Collaborative care
In collaborative care, the primary care clinician works with a mental health specialist, a care manager, and the patient, using scheduled symptom checks and coordinated treatment changes. This model can be particularly useful when patients have several chronic illnesses, limited mobility or complex medication regimens. The randomized IMPACT study found substantially better depression outcomes in older adults assigned to collaborative care than usual primary care. Coordinated care treats depression as an ongoing clinical and functional problem rather than a one-visit prescription.
23. Exercise, sleep, social activity and rehabilitation
Medical-appropriate walking, chair-based exercises, physical rehabilitation, consistent sleep routines, nutritious meals, and meaningful activity can complement indicated psychological and medical care. Goals should fit cardiovascular health, pain, balance, energy, and personal preference. Behavioral activation may begin with a short supported walk or returning to one valued hobby; transportation and mobility assistance may be necessary to make social activities accessible. Such measures support treatment but do not replace specialist assessment for severe, suicidal, or psychotic depression. NIA guidance.
VII. Treatment-Resistant Depression and Advanced Interventions
When an older patient has not improved, clinicians reevaluate the diagnosis, adequacy and duration of previous treatments, adherence, interactions, access, comorbid disorders, and physical or cognitive contributors. Treatment-resistant depression is often defined for research or services as inadequate response to at least two adequate antidepressant trials, although definitions vary. A poor response to one medication does not establish that depression is untreatable. Complex treatment should be managed collaboratively with appropriate specialist expertise.
24. What the OPTIMUM trial showed
The OPTIMUM randomized trial, published in the New England Journal of Medicine in 2023, enrolled adults age 60 or older with treatment-resistant depression. In the first approximately ten-week open-label comparison, augmentation with aripiprazole improved psychological well-being more than switching to bupropion. Remission occurred in 28.9% receiving aripiprazole augmentation, 28.2% receiving bupropion augmentation, and 19.3% switched to bupropion. Falls were most frequent with bupropion augmentation. The study also examined lithium augmentation and switching to nortriptyline in a later step. These findings inform discussions of selected strategies, not a universal drug ranking; antipsychotic augmentation, lithium and tricyclic medication all require attention to specific adverse effects and monitoring.
25. Electroconvulsive therapy
Electroconvulsive therapy (ECT) is an established specialist option for selected severe, psychotic, medically urgent, or treatment-resistant depressive episodes. It uses a controlled seizure under anesthesia and medical monitoring. Evaluation considers physical illness, anesthesia risk, cognition, memory effects, alternatives, consent, and personal preference. In the PRIDE geriatric depression study, an initial course of right-unilateral ultrabrief-pulse ECT with venlafaxine was associated with remission in 61.7% of participants. That phase was not a randomized comparison with other acute treatments; its remission rate should not be presented as a guaranteed outcome.
26. TMS, ketamine and esketamine
Repetitive transcranial magnetic stimulation may be suitable for selected adults with major depression under an established clinical protocol. Evidence specific to the oldest and medically frail patients is less extensive than overall adult evidence, so eligibility and safety require individual consideration. Ketamine and intranasal esketamine have specialized roles under applicable clinical and regulatory requirements, including controlled monitoring. Evidence from general adult studies cannot automatically be extended to every older population or level of frailty. These procedures are evaluated and provided by appropriately qualified clinicians rather than undertaken independently. NICE treatment guidance informs escalation and the use of specialist services.
VIII. Special Situations in Later Life
27. After stroke or other serious illness
Depression may develop or worsen after stroke, surgery, severe infection, major hospitalization, or the onset of a disabling chronic disease. Physical consequences, medication changes, disrupted sleep and changes in independence interact. Rehabilitation and psychiatric care may need to proceed together. New neurologic findings, acute confusion, or severe physical decline should still receive direct medical assessment and cannot be attributed automatically to low mood.
28. With chronic pain or reduced mobility
Persistent pain and reduced mobility can restrict valued activities, disrupt sleep and complicate access to psychotherapy. Depression can add hopelessness and decrease activity, which may further reduce function. Coordinated plans address both conditions, relevant medications, physical therapy or rehabilitation, accessible transport and feasible daily goals. A patient's difficulty engaging should not automatically be interpreted as unwillingness to recover.
29. With mild cognitive impairment or dementia
Where cognitive problems coexist with depressive symptoms, clinicians may adapt communication and treatment, consider assistance with remembering appointments, and involve caregivers with consent. Decisions should preserve autonomy and reflect the older adult's capabilities and preferences. If the person has a diagnosed neurocognitive disorder, depression treatment complements continuing neurocognitive care. Persistent cognitive deficits after mood improvement merit further evaluation.
30. Nursing homes, rural areas and access barriers
Care decisions must recognize the realities of institutional living, hearing impairment, low digital literacy, financial constraints, limited transportation, and uneven access to geriatric psychiatry or therapy. Telehealth helps some people, while others need in-person or accessible outreach. Cultural and language factors affect how distress is described and understood. Care quality depends partly on whether a treatment recommendation can be carried out reliably with the available support.
IX. How Families and Caregivers Can Help
Notice changes from the older person's customary pattern: neglected meals, lost interest, withdrawal, confusion, fatigue, reduced personal care, missed appointments, or statements of hopelessness. Ask a direct, respectful question about how they have been feeling and what tasks have become harder. Avoid arguments that they should simply be grateful or cheerful. Explain that there are treatable causes and offer one achievable next step, such as contacting primary care or a mental health clinician.
31. Preparing for an appointment
Bring a timeline of symptoms and functional changes, a list of medications including supplements, information about recent falls, medical events, sleep and appetite changes, memory concerns, previous mood episodes, and any statements about death or safety. Glasses and hearing devices can improve communication. A trusted family member can attend if invited by the older adult. Ask the clinician what is being considered, how improvement will be tracked, when to follow up, and what adverse effects require contact.
32. Supporting independence
Support is more effective when it includes the older person's goals. Ask whether they would like help arranging transportation, maintaining social contact, participating in a valued activity, preparing medication questions, or managing appointments. Depression, old age and hearing difficulty do not automatically remove capacity for decision-making. Information can be made easier to understand through shorter explanations, written summaries, additional time and trusted assistance. Acute danger, however, can require urgent protective assessment.
33. What caregivers need
Caring for a depressed family member can be demanding, especially when the caregiver is also managing work, illness or another dependent relative. Sharing practical tasks, arranging clinical follow-up, and identifying reliable backup contacts can make the care plan sustainable. Caregivers should seek their own support if strain becomes significant and avoid assuming responsibility for decisions requiring a clinician's expertise. The goal is collaborative, respectful care, not surveillance or blame.
X. Suicide Risk, Psychosis, and Medical Emergencies
Suicidal intent or plans, inability to remain safe, new hallucinations or delusions, extreme neglect of basic needs, refusal of fluids or food, and abrupt changes in consciousness or attention require urgent evaluation. Expressions such as feeling like a burden or wishing not to wake up should be taken seriously. Ask directly about safety and involve qualified professionals; a screening score cannot substitute for an assessment of immediate danger. Acute confusion can be delirium or another medical emergency and needs prompt medical assessment.
For an immediate life-threatening emergency in the United States, call 911. In a suicidal crisis in the United States, call or text 988. Elsewhere, use the relevant local emergency and crisis services. Stay with a person in immediate danger if it is safe and help emergency responders obtain the clinical history. NIMH guidance for older adults provides additional help-seeking information.
XI. Recovery, Relapse and Follow-Up
Improvement may occur gradually. A person's sleep or appetite may improve before pleasure and confidence return. Clinical response indicates a meaningful reduction in symptoms, remission indicates symptoms below a defined threshold, recovery refers to sustained remission, relapse denotes worsening before stable recovery, and recurrence denotes a new depressive episode after recovery. Definitions differ across research and services. Depression can recur after successful treatment, so an agreed follow-up and early-warning plan is useful.
Follow-up should review mood, anhedonia, daily functioning, adverse effects, medication burden, falls, cognition, sleep, pain and personal goals. Patients with recurrent episodes may benefit from a longer continuation or maintenance strategy selected with the clinician. When treatment is stopped, medication withdrawal must be distinguished from relapse. NICE NG222 provides principles for continuation, relapse prevention and tapering.
XII. Frequently Asked Questions
34. Is it normal to become depressed after 65?
Depression is a treatable clinical condition, not a normal consequence of age. Life transitions and chronic illness can influence risk, but persistent depressive symptoms merit appropriate assessment regardless of age. NIA.
35. Can depression cause memory loss?
Depression can interfere with concentration, retrieval and planning, causing genuine cognitive difficulties. Some improve when depression is treated; others persist or coexist with neurocognitive disease. Assessment needs to consider both mood and cognition.
36. Can the Geriatric Depression Scale diagnose major depression?
No. It is a screening instrument. Positive results call for a clinical assessment of symptoms, impairment, duration, physical conditions, medication effects and other psychiatric conditions. The USPSTF recommends screening within a pathway that provides evaluation and care.
37. Are antidepressants safe for people over age 65?
They can be helpful, but safety depends on the individual drug, comorbid illnesses, other medications, prior falls, sodium-related risks and monitoring. No single medicine is universally safe for every older adult. Decisions are made with a prescriber. NICE recommendations.
38. Is psychotherapy still effective in old age?
Evidence-based psychotherapy is a valid treatment option and can be adapted to age-related practical needs. The APA recommends appropriate modalities. Evidence in long-term care settings is promising but very uncertain according to the 2024 Cochrane review.
39. What happens if the first treatment fails?
Clinicians reassess diagnosis, treatment adequacy, side effects, adherence, comorbid medical problems and other stressors. A different psychological intervention, medication adjustment, combined care or specialist referral may be considered. The OPTIMUM trial informs some strategies for older adults with treatment-resistant depression.
40. Is sudden confusion a symptom of depression?
Depression can affect concentration and thinking, but sudden or fluctuating confusion may be delirium or another acute medical problem. It requires prompt medical assessment, especially with illness, medication changes, or reduced alertness.
41. Can depression return after remission?
Yes. Recurrence is possible, and a plan for follow-up, early warning signs, maintenance care and safe medication changes can improve responsiveness if symptoms return. NICE NG222.
XIII. Summary
Depression in older adults can affect emotion, bodily experience, daily function and cognition. Clinical diagnosis requires the full symptom pattern and differential evaluation rather than age stereotypes or a screening score. Coexisting physical illness, polypharmacy, dementia, delirium, bipolar history and safety concerns shape clinical decisions. Psychotherapy, tailored pharmacotherapy, collaborative care, and selected specialist interventions provide treatment pathways. Families can support recovery by noticing change, making care accessible, respecting autonomy and seeking urgent care when needed.
Related Articles
References
American Psychological Association. (n.d.). Depression treatments for older adults. APA guidance.
Davison, T. E., Bhar, S., Wells, Y., et al. (2024). Psychological therapies for depression in older adults residing in long-term care settings. Cochrane Database of Systematic Reviews, CD013059. DOI: 10.1002/14651858.CD013059.pub2.
Kellner, C. H., Husain, M. M., Knapp, R. G., et al. (2016). Right unilateral ultrabrief pulse ECT in geriatric depression: Phase 1 of the PRIDE study. American Journal of Psychiatry. DOI: 10.1176/appi.ajp.2016.15081101.
Lenze, E. J., Mulsant, B. H., Roose, S. P., et al. (2023). Antidepressant augmentation versus switch in treatment-resistant geriatric depression. New England Journal of Medicine, 388, 1067–1079. DOI: 10.1056/NEJMoa2204462.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). NICE recommendations.
National Institute of Mental Health. (n.d.). Depression. NIMH publication.
National Institute of Mental Health. (n.d.). Older adults and mental health. NIMH topic page.
National Institute on Aging. (n.d.). Depression and older adults. NIA resource.
National Institute on Aging. (n.d.). Four things to know about depression and older adults. NIA resource.
Unützer, J., Katon, W., Callahan, C. M., et al. (2002). Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. JAMA, 288, 2836–2845. JAMA article.
U.S. Preventive Services Task Force. (2023). Depression and suicide risk in adults: Screening. USPSTF recommendation.